An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
NCT01873729
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG:
Naltrexone
Sponsor
Massachusetts General Hospital